Not a single study
Story checked
Children with a common genetic variant may have more inflammation in response to an asthma drug (opens in a new tab)
medicalxpress.com · 2026-10-01
Short answer
Not a single studyNo clear answer.
The article covers a research area rather than reporting a specific new paper, so there is no single study to check it against.
Checked against the study summary. The full text wasn't available, so some details couldn't be settled either way.
Share this check
The story
Children with a common genetic variant may have more inflammation in response to an asthma drug
medicalxpress.com · 2026-10-01
The story’s checkable claims.
Read the original story (opens in a new tab)NewsLink checks it
This story isn't reporting one study.
The article covers a research area rather than reporting a specific new paper, so there is no single study to check it against.
Open claim evidenceSearch result
No single source study.
The article covers a research area rather than reporting a specific new paper, so there is no single study to check it against.
Source layer
The paper behind the story
The source record for this check.
The research anchor for the report.
- Also referencedpresented as the new finding
Journal of Allergy and Clinical Immunology (2026)
Evidence layer
Claim by claim
What the story asserts. With no source study, there is nothing to check these against.
Reading mode
Scan verdicts. Open evidence only when needed.
Claim 1 of 4Not checkedChildren with a variant in the SERPINE1 gene, found in about 60% of the population, may be less responsive to mepolizumab, a drug used to treat asthma flares.View evidenceHide evidence
As statedabout 60% of the population
Not checked
NewsLink could not identify one source study, so this claim was not compared against a paper.
Claim 2 of 4Not checkedThe study found that this genetic variant leads to increased production of PAI1 during a viral illness, resulting in more airway scarring and a weaker antiviral response.View evidenceHide evidence
Not checked
NewsLink could not identify one source study, so this claim was not compared against a paper.
Claim 3 of 4Not checkedWhen patients with the variant receive mepolizumab, the drug stimulates additional inflammatory pathways that damage the airway, while those changes do not occur in patients without the variant.View evidenceHide evidence
Not checked
NewsLink could not identify one source study, so this claim was not compared against a paper.
Claim 4 of 4Not checkedKumar cautioned that the results describe what happens in the airways during a viral illness and in response to mepolizumab, rather than what would be seen clinically, and that the study was not large enough to support a clinical conclusion.View evidenceHide evidence
Not checked
NewsLink could not identify one source study, so this claim was not compared against a paper.
Method layer
No single source study was found.
NewsLink still surfaces nearby research so you can inspect the field instead of a single paper.
Nearby research
No exact source, but these papers are close.
PubMed, Crossref, Europe PMC · 15 candidate papers
Integrated Transcriptomic and Functional Analyses Identify SERPINE1 as a Ferroptosis-Associated Mediator of Glioblastoma Radioresistance.
Frontiers in Bioscience (Landmark Edition) · 2026 · PubMed
Differences in viral etiologies in asthma and wheezing illness in young children
2018 · Crossref
Fibrotic chronic eosinophilic pneumonia: from inflammation to fibrosis and therapeutic implications.
2026 · Europe PMC
Transient ultrastructural remodeling of the open canalicular system and α-granules is associated with endothelial responses after BNT162b2 vaccination in healthy volunteers.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie · 2026 · PubMed
Atopic Sensitization is Associated With Severe Lower Respiratory Illness in Children With Pandemic H1N1 Influenza Viral Infection
Allergy, Asthma & Immunology Research · 2012 · Crossref
And 10 more candidates considered.